Finny logo
Finny logo
Dibs:
Dibs:
0

DaVita (DVA) earnings: expect -2% revenue decline

4:22 am ET, 05 May 2019

DaVita Inc. (DVA) is announcing earnings on May 07, after the market closes. Wondering what revenue and earnings will look like?

What should you expect from the upcoming earnings?

Revenue for the next quarter is expected to be $2.82B, which implies a -2% growth rate year-over-year.

Earnings per share are expected to come in at $0.95. If this materializes, EPS will decline -10% year-over-year.

How did the stock do last month?

Over the last month, DaVita Inc. (DVA) returned +4.75%.

What do analysts say about the stock?

DaVita Inc. (DVA) average analyst price target is 20.93% above its current price ($55.24).

For the latest price and information on DaVita Inc., please visit Finstead and ask for "DVA", "DVA analysis" or "DVA news".

Powered by Froala Editor

DaVita Inc. (DVA) Stock Guide

Updated at: 5:07 pm ET, 17 Sep 2020

Before we start: if you're looking for DVA stock price, you can quickly find it out by visiting Finny and typing "DVA quote". If you're looking for a quick scoop on DVA stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for "DVA". You'll get all this info in one place. Or you can just type "DVA news" to get the latest stock news.

Looking to buy or sell DaVita Inc. (DVA)? Interested in getting the full scoop on DVA, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

In this DVA stock guide, we'll address key questions about DVA, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.

Here is what you'll be able to find in this guide:

Earnings and Dividends: earnings, earnings date, dividend rate and dividend yield;
Analyst Predictions: stock forecast and analyst ratings;
Analysis: Finny Score and buy or sell analysis;
Key Stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio, industry, sector, and number of employees.

And here is the list of questions we'll answer:
1. What are DVA earnings?
2. What is DVA stock forecast (i.e., prediction)?
3. DVA buy or sell? What is DVA Finny Score?
4. What are the reasons to buy DVA? Why should I buy DVA stock?
5. What are the reasons to sell DVA? Why should I sell DVA stock?
6. What are DVA key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

So let's start. Scroll down to the question that interests you the most.

Earnings and Dividends

1. What are DVA earnings?

DVA trailing 12-month earnings per share (EPS) is $6.22.

Analyst Predictions

2. What is DVA stock forecast (i.e., prediction)?

Based on DVA analyst price targets, DVA stock forecast is $97.20 (for a year from now). That means the average analyst price target for DVA stock is $97.20. The prediction is based on 13 analyst estimates.

The low price target for DVA is $85.00, while the high price target is $105.00.

DVA analyst rating is Hold.

Analysis

3. DVA buy or sell? What is DVA Finny Score?

#{finnyScore:13}Our quantitative analysis shows 1 reason to buy and 7 reasons to sell DVA, resulting in Finny Score of 13.

4. What are the reasons to buy DVA? Why should I buy DVA stock?

Here are the reasons to buy DVA stock:

  • A global increase in obesity and diabetes-related conditions should sustain strong demand for dialysis services over the long term.
  • DaVita's large dialysis operations help sustain its low-cost leadership, which helps insulate the company from reimbursement pressure affecting the whole industr
  • The HealthCare Partners segment has high growth potential as the U.S. healthcare industry shifts toward more value-based and risk-sharing reimbursement plans.
  • DVA cash to debt ratio is 0.24, higher than the average industry (0.13) and sector (0.16) cash to debt ratio. See DVA cash to debt chart.

5. What are the reasons to sell DVA? Why should I sell DVA stock?

Let's look at the reasons to sell DVA stock (i.e., the bear case):

  • DaVita's profitability is largely dependent on commercial payers. Future contract negotiations or greater-than-expected patient shifts into lower-paying exchange plans could adversely affect DaVita's bottom line.
  • Federal government changes to Medicare and state budget constraints on Medicaid should keep dialysis reimbursement growth subdued.
  • Medicare Advantage cuts have eroded profitability in the HealthCare Partners segment beyond management's initial estimates.
  • DVA stock price ($90.14) is close to the 52-week high ($92.40). Perhaps now is a good time to sell? See DVA price chart.
  • DVA profitability is declining. The YoY profit margin change was -4.70 percentage points. See DVA profitability chart.
  • DVA Price/Book ratio is 4.95, which is high compared to its industry peers’ P/B ratios. See DVA forward Price/Book ratio chart.
  • DVA Price/Sales ratio is 0.92, which is high compared to its industry peers’ P/S ratios. See DVA forward Price/Sales ratio chart.
  • DVA short share of float is 6.15%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock. See DVA short share of float chart.
  • DVA short interest (days to cover the shorts) ratio is 6.27. The stock garners more short interest than the average industry, sector or S&P 500 stock. See DVA short interest ratio chart.
  • DVA Enterprise Value/Revenue multiple is 1.90, which is high compared to its industry peers’ Enterprise Value/Revenue multiples. See DVA Enterprise Value/Revenue chart.

Key Stats

6. What are DVA key stats : revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

Let's look at the key statistics for DVA:

Metrics DVA
Price $86.25
Average Price Target / Upside $97.80 / 13.40%
Average Analyst Rating Hold
Forward Dividend Yield 0.00%
Industry Medical Care
Sector Healthcare
Number of Employees 77,700
Market Cap $10.84B
Forward P/E Ratio 11.88
Price/Book Ratio 0.94
Revenue (TTM) $11.52B
YoY Quarterly Revenue Growth 1.30%
Profit Margin 7.20%

If you liked this analysis, check out Stock Guides for other stocks.

Follow Us